We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSBC
7351
DELISTED
FSB Bancorp, Inc. Common Stock
FSBC
$9K ﹤0.01%
511
-1,123
-69% -$19.1K
BKJ
7352
DELISTED
Bancorp of New Jersey, Inc.
BKJ
$9K ﹤0.01%
500
-361
-42% -$6.6K
SKYS
7353
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$9K ﹤0.01%
5,816
+794
+16% +$1.2K
DTYS
7354
DELISTED
iPath US Treasury 10-year Bear ETN
DTYS
$9K ﹤0.01%
667
-1,886
-74% -$21.5K
ACHV icon
7355
Achieve Life Sciences
ACHV
$684M
$8K ﹤0.01%
766
+603
+370% +$12.9K
ALTO icon
7356
Alto Ingredients
ALTO
$392M
$8K ﹤0.01%
12,288
+11,596
+1,676% +$6.57K
ARGT icon
7357
Global X MSCI Argentina ETF
ARGT
$836M
$8K ﹤0.01%
+305
New +$7.13K
BBGI icon
7358
Beasley Broadcasting Group
BBGI
$44.7M
$8K ﹤0.01%
125
BW icon
7359
Babcock & Wilcox
BW
$1.42B
$8K ﹤0.01%
2,110
-2,484
-54% -$9.7K
CNVS icon
7360
Cineverse
CNVS
$62.8M
$8K ﹤0.01%
636
+482
+313% +$8.3K
CPIX icon
7361
Cumberland Pharmaceuticals
CPIX
$113M
$8K ﹤0.01%
+1,546
New +$8.16K
CVEO icon
7362
Civeo
CVEO
$338M
$8K ﹤0.01%
547
-7
-1% -$88
DTSS icon
7363
Datasea Intelligent Technology Ltd
DTSS
$8.72M
$8K ﹤0.01%
+185
New +$5.93K
DXLG icon
7364
Destination XL Group
DXLG
$30.7M
$8K ﹤0.01%
+6,421
New +$9.06K
FAT
7365
DELISTED
FAT Brands
FAT
$8K ﹤0.01%
3,403
+695
+26% +$1.7K
IGC icon
7366
IGC Pharma
IGC
$26.3M
$8K ﹤0.01%
12,829
+9,916
+340% +$8.11K
JDST icon
7367
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$23.5M
-1
Closed -$72.5K
JFIN
7368
Jiayin Group
JFIN
$145M
$8K ﹤0.01%
+1,532
New +$12.5K
KELYB
7369
Kelly Services Class B
KELYB
$778M
$8K ﹤0.01%
351
+1
+0.3% +$22
MTNB icon
7370
Matinas BioPharma
MTNB
$1.76M
$8K ﹤0.01%
+72
New +$4.17K
NUSA icon
7371
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$34.5M
$8K ﹤0.01%
321
-1,624
-83% -$40.6K
PANL icon
7372
Pangaea Logistics
PANL
$474M
$8K ﹤0.01%
+2,741
New +$8.57K
PROF
7373
Profound Medical
PROF
$304M
$8K ﹤0.01%
+700
New +$6.45K
AIXC
7374
AIxCrypto Holdings Inc
AIXC
$15.6M
$8K ﹤0.01%
+4
New +$11.5K
RELL icon
7375
Richardson Electronics
RELL
$308M
$8K ﹤0.01%
1,334
+65
+5% +$369

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.